Free Trial

Northwest Biotherapeutics (OTCMKTS:NWBO) Stock Crosses Below 200-Day Moving Average - What's Next?

Northwest Biotherapeutics logo with Medical background

Northwest Biotherapeutics, Inc. (OTCMKTS:NWBO - Get Free Report) shares passed below its 200-day moving average during trading on Wednesday . The stock has a 200-day moving average of $0.31 and traded as low as $0.28. Northwest Biotherapeutics shares last traded at $0.29, with a volume of 2,079,674 shares changing hands.

Northwest Biotherapeutics Stock Performance

The stock has a market cap of $416.19 million, a PE ratio of -3.90 and a beta of -0.50. The business has a 50 day moving average price of $0.27 and a two-hundred day moving average price of $0.31.

Northwest Biotherapeutics (OTCMKTS:NWBO - Get Free Report) last announced its quarterly earnings data on Tuesday, November 12th. The biotechnology company reported ($0.02) EPS for the quarter. The business had revenue of $0.36 million for the quarter.

About Northwest Biotherapeutics

(Get Free Report)

Northwest Biotherapeutics, Inc, a biotechnology company, develops personalized immune therapies for cancer in the United States and internationally. The company develops its products based on DCVax, a platform technology that uses activated dendritic cells to mobilize a patient's own immune system to attack cancer.

Further Reading

Should You Invest $1,000 in Northwest Biotherapeutics Right Now?

Before you consider Northwest Biotherapeutics, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Northwest Biotherapeutics wasn't on the list.

While Northwest Biotherapeutics currently has a "Hold" rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

The Next 7 Blockbuster Stocks for Growth Investors Cover

Wondering what the next stocks will be that hit it big, with solid fundamentals? Enter your email address to see which stocks MarketBeat analysts could become the next blockbuster growth stocks.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Palantir’s Explosive Growth: Buy Now or Wait for a Dip?
5 Stocks to BUY NOW in February 2025
How To Invest in Crypto as A Complete BEGINNER in 2025

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines